Munich Re Q2 2026 Results Overview
Munich Reinsurance (ETR:MUVGn) reported second‑quarter 2026 net profit of €2.2 billion (approximately $2.5 billion), up from €2.1 billion a year earlier and in line with the preliminary earnings disclosed in late July. The result exceeded the analyst consensus estimate of about €1.79 billion.
Shares fell more than 4 % on Friday following the release, as the market reacted to pressure in the property‑and‑casualty (P&C) reinsurance division.
P&C reinsurance revenue declined roughly 15 % year‑on‑year, and the division’s combined ratio deteriorated to 68.9 % in the quarter, compared with 61.0 % a year earlier. After adjusting for one‑off items, the normalized combined ratio was around 82 %, below the company’s full‑year guidance of roughly 80 % and within the target range of 79‑83 % cited by Morgan Stanley analysts.
Consequently, Munich Re cut its top‑line guidance for the P&C segment to €38 billion, down from the previous €40 billion outlook.
Investment‑linked earnings rose sharply to €3.16 billion from €2.19 billion in the prior year, delivering a 5.5 % return on the average market value of the investment portfolio, driven largely by rising equity markets.
Life and health reinsurance generated a technical result of €528 million, supported by the completion of the company’s largest longevity transaction to date, which covered €4 billion of pension liabilities.
The Global Specialty Insurance unit posted a combined ratio of 88.9 %, up from 77.9 % a year earlier, after a comparatively weak major‑loss quarter in the prior period. The unit highlighted growth opportunities in U.S. real‑estate, professional liability and European surety lines.
ERGO, Munich Re’s primary insurance arm, reported profit of €321 million, up from €251 million in the same quarter last year, surpassing its pro‑rata annual guidance thanks to a stronger investment result.
The company reaffirmed its full‑year profit guidance of €6.3 billion.
Vahid Karaahmetovic contributed to this report.